| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Spyre Therapeutics, Inc. (SYRE) has 10 insiders with recent SEC Form 4 filings, including 2 buys and 13 sells. SYRE is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 597.5K | $52.79M | -15,000 | |
| Other | 313.3K | $27.68M | -8,333 | |
| Other | 140.0K | $12.37M | - | |
| CFO | 103.7K | $9.16M | -7,500 | |
| Dir | 8.0K | $709.0K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Feb 2, 2026 | Turtle Cameron | Chief Executive Officer | Sell | 15,000 | $32.80 | $492,045.15 | -1.1% | +112.0% | - | |
| Jan 2, 2026 | Turtle Cameron | Chief Executive Officer | Sell | 15,000 | $30.68 | $460,134.12 | -0.7% | +59.9% | - | |
| Dec 1, 2025 | Turtle Cameron | Chief Executive Officer | Sell | 15,000 | $29.02 | $435,355.50 | -1.1% | +48.2% | - | |
| Nov 3, 2025 | Turtle Cameron | Chief Executive Officer | Sell | 45,000 | $23.33 | $1,049,777.85 | -3.1% | +37.7% | - | |
| Sep 2, 2025 | Burrows Scott L74 | Chief Financial Officer | Sell | 18,428 | $16.26 | $299,639.28 | -15.8% | +72.3% | - | |
| Nov 6, 2024 | Albers Jeffrey W.65 | Director | Sell | 6,700 | $36.76 | $246,312.77 | -19.7% | -36.8% | -40.3% | |
| Oct 25, 2024 | Albers Jeffrey W.65 | Director | Sell | 300 | $36.43 | $10,929.00 | -0.9% | -37.3% | -32.9% | |
| Sep 3, 2024 | Burrows Scott L74 | Chief Financial Officer | Sell | 18,531 | $28.17 | $522,073.86 | -13.7% | +3.9% | -36.8% | |
| Aug 25, 2022 | Souza Marcio63 | Director | Buy | 90,000 | $0.56 | $50,472.00 | New | +131.4% | 0.0% | |
| Jun 8, 2022 | Hanley Jr. Michael Conick | Chief Commercial Officer | Buy | 28,200 | $0.71 | $20,022.00 | +352.5% | -30.0% | -81.5% |